The gut–brain–circadian axis in anxiety and depression: a critical review
Top Cited Papers
Open Access
- 30 October 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 16, 1697200
Abstract
Anxiety and depressive disorders rank among the most prevalent psychiatric conditions worldwide, yet remission rates remain unsatisfactory despite advances in pharmacological and psychotherapeutic interventions. The gut–brain axis has emerged as a transformative framework for understanding these disorders, emphasizing bidirectional communication between the central nervous system, the enteric nervous system, the endocrine and immune systems, and the gut microbiota. Preclinical studies demonstrate that germ-free or dysbiotic states exaggerate hypothalamic–pituitary–adrenal (HPA) reactivity, remodel synaptic plasticity, and induce anxiety- and depression-like behaviors, while fecal microbiota transplantation confirms the causal influence of microbial communities. Mechanistically, neural (e.g., vagal), endocrine (e.g., cortisol), immune (e.g., cytokine), and metabolic (e.g., short-chain fatty acids, tryptophan metabolites, bile acids) pathways converge to regulate mood and stress resilience. An underappreciated yet critical dimension of this model is circadian rhythmicity. Both host endocrine cycles and microbial communities exhibit diurnal oscillations that synchronize metabolism, immune activity, and neural signaling. Disruption of these rhythms, through factors such as sleep disturbance, irregular feeding, or shift work, alters microbial diversity, dampens metabolite oscillations, destabilizes HPA regulation, and enhances neuroinflammation, thereby amplifying vulnerability to psychiatric disorders. Collectively, evidence supports a model in which anxiety and depression are systemic conditions arising from integrated neural, immune, endocrine, metabolic, and circadian dysregulation, rather than isolated brain-based pathologies. This reconceptualization positions microbial taxa and metabolites as candidate biomarkers and therapeutic targets. Precision interventions, ranging from diet and psychobiotics to fecal microbiota transplantation, chrononutrition, and immune-modulatory strategies, offer promising avenues for personalized psychiatry.Keywords
This publication has 197 references indexed in Scilit:
- A Peripheral Mechanism of Depression: Disturbed Intestinal Epithelial Per2 Gene Expression Causes Depressive Behaviors in Mice with Circadian Rhythm Disruption via Gut Barrier Damage and Microbiota DysbiosisAdvanced Science, 2025
- Unraveling the Gut‐Brain‐Immune Interplay in Herpes Simplex Virus‐Associated NeurodegenerationJournal of Medical Virology, 2025
- Effects of microbiota‐based interventions on depression and anxiety in children and adolescents—A systematic reviewJournal of Pediatric Gastroenterology and Nutrition, 2025
- Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and TherapyMedcomm, 2025
- Worldwide Prevalence and Disability From Mental Disorders Across Childhood and AdolescenceJAMA Psychiatry, 2024
- Circadian modulation of microglial physiological processes and immune responsesGlia, 2022
- Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and ObesityJAMA Internal Medicine, 2020
- Regulation of the Hypothalamic‐Pituitary‐Adrenocortical Stress Response2016
- Role of Translocator Protein Density, a Marker of Neuroinflammation, in the Brain During Major Depressive EpisodesJAMA Psychiatry, 2015
- A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant DepressionJAMA Psychiatry, 2013